RECRUITING

Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Caregiver-child dyads will be recruited during child's hospital admission for asthma exacerbation. Recruitment sites will be mainly Children's National Hospital Sheikh Zayed campus, as well as regional partners: Holy Cross Hospital, and Mary Washington Hospital. After enrollment, baseline data will be collected from caregiver. Caregiver-child dyads will be randomized (1:1 ratio) into the control arm or intervention arm. Control arm will receive the standard of care after hospital discharge. Intervention arm will receive the SOC plus an asthma navigator support after hospital discharge. Caregivers in both arms will complete data collection surveys (either in-person or via telehealth) at 3-,6-, 9-, and 12- month post enrollment.

Official Title

The Hospital to Home Study: a Pragmatic Trial to Optimize Transitions and Address Disparities in Asthma Care

Quick Facts

Study Start:2024-01-22
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05991115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:4 Years to 12 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. 1. speak English or Spanish
  2. 2. are at least 18 years old
  3. 3. live in the District of Columbia, Maryland, or Virginia (DMV)
  4. 4. have a child aged 4-12 years who is hospitalized due to asthma exacerbation.
  1. 1. . Children ages 4-12 years with chronic medical condition (other than asthma) including but not limited to diabetes, sickle cell disease, heart disease, lung disease or neurological disorder
  2. 2. . Children ages 4-12 years involved in interventions with behavioral component and/or novel asthma therapeutics will be excluded given overlap with the current intervention
  3. 3. . Children ages 4-12 years in foster care
  4. 4. . Families not residing in the DMV
  5. 5. . Caregivers who do not speak English or Spanish

Contacts and Locations

Study Contact

Kavita Parikh, MD MSHS
CONTACT
2024766366
kparikh@childrensnational.org
Alicia Mathis
CONTACT
2024764698
anewcome@childrensnational.org

Principal Investigator

Kavita Parikh, MD MSHS
PRINCIPAL_INVESTIGATOR
Children's National Research Institute

Study Locations (Sites)

Children's National Hospital
Washington DC, District of Columbia, 20010
United States

Collaborators and Investigators

Sponsor: Kavita Parikh

  • Kavita Parikh, MD MSHS, PRINCIPAL_INVESTIGATOR, Children's National Research Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-22
Study Completion Date2027-12

Study Record Updates

Study Start Date2024-01-22
Study Completion Date2027-12

Terms related to this study

Keywords Provided by Researchers

  • asthma
  • hospitalization
  • children

Additional Relevant MeSH Terms

  • Asthma
  • Asthma in Children